Clinical trial
Caelyx Adjuvant in Elderly Breast Cancer
NCT00284336 · Universitaire Ziekenhuizen KU Leuven, Other · Completed
Key facts
| NCT number | NCT00284336 |
|---|---|
| Title | Caelyx Adjuvant in Elderly Breast Cancer |
| Official title | An Open Label Phase II Trial to Investigate the Cardiac Effects of Pegylated Liposomal Doxorubicine (Caelyx) in Elderly Breast Cancer Patients With New Imaging and Biochemical Techniques. |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Elderly |
| Intervention type | Drug |
| Interventions | Caelyx, endoxan |
| Enrollment | 16 |
| Start date | Jan 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jan 31, 2006 |
| Last update posted | Dec 9, 2014 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: